Back to Search Start Over

Production of the PET isotope 11 C in hadron therapy via neutron knockout.

Authors :
Simpson EC
Source :
Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) [Phys Med] 2016 Dec; Vol. 32 (12), pp. 1813-1818. Date of Electronic Publication: 2016 Oct 11.
Publication Year :
2016

Abstract

Purpose: Positron emitting isotopes such as <superscript>11</superscript> C and <superscript>10</superscript> C can be used for vital dose verification in hadron therapy. These isotopes are produced when the high energy <superscript>12</superscript> C primary beam particles undergo nuclear reactions within the patient.<br />Methods: We discuss a model for calculating cross sections for the production <superscript>11</superscript> C in <superscript>12</superscript> C+ <superscript>12</superscript> C collisions, applicable at hadron therapy energies.<br />Results: Good agreement with the available cross section measurements is found for <superscript>12</superscript> C(-1n), though more detailed, systematic measurements would be very valuable.<br />Conclusions: Nuclear structure plays a crucial role in the reactions of light nuclei, particularly when those reactions are peripheral and involve only a few nucleons. For such reactions, nuclear structure has a strong influence on the energy and angular distribution of the cross section, and is an important consideration for reliable dose verification using <superscript>11</superscript> C in hadron therapy.<br /> (Copyright © 2016. Published by Elsevier Ltd.)

Details

Language :
English
ISSN :
1724-191X
Volume :
32
Issue :
12
Database :
MEDLINE
Journal :
Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
Publication Type :
Academic Journal
Accession number :
27742257
Full Text :
https://doi.org/10.1016/j.ejmp.2016.09.005